Abstract:Carcinogens, such as arecoline, play a crucial role in cancer progression and continuous gene mutations by generating reactive oxygen species (ROS). Antioxidants can reduce ROS levels and potentially prevent cancer progression but may paradoxically enhance the survival of cancer cells. This study investigated whether epigallocatechin-3-gallate (EGCG), an antioxidant from green tea, could resolve this paradox. Prostate cancer cells (PC-3 cell line) were cultured and treated with arecoline combined with NAC (N-acetylcysteine) or EGCG; the combined effects on intracellular ROS levels and cell viability were examined using the MTT and DCFDA assays, respectively. In addition, apoptosis, cell cycle, and protein expression were investigated using flow cytometry and western blot analysis. Our results showed that EGCG, similar to NAC (N-acetylcysteine), reduced the intracellular ROS levels, which were elevated by arecoline. Moreover, EGCG not only caused cell cycle arrest but also facilitated cell apoptosis in arecoline-treated cells in a synergistic manner. These were evidenced by elevated levels of cyclin B1 and p27, and increased fragmentation of procaspase-3, PARP, and DNA. Our findings highlight the potential use of EGCG for cancer prevention and therapy.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore whether epigallocatechin - 3 - gallate (EGCG) can act as an effective antioxidant and synergistically enhance the cytotoxic effect of the carcinogen arecoline on prostate cancer cells without protecting cancer cells. Specifically, the study aims to verify whether EGCG can enhance the cytotoxic effect of arecoline by redirecting cell - cycle arrest to apoptosis, thereby providing new strategies for cancer prevention and treatment. ### Research Background - **Arecoline and Cancer**: Arecoline is a substance extracted from betel nuts, which can increase the production of reactive oxygen species (ROS) and thus promote the development of cancer. The generation of ROS can lead to damage to lipids, proteins and DNA, initiating the cancer development process. - **The Antioxidant Paradox**: Although antioxidants such as N - acetylcysteine (NAC) can reduce ROS levels, they may unexpectedly provide cancer cells with a survival advantage, leading to the proliferation of cancer cells and treatment resistance. - **The Mechanism of Action of EGCG**: EGCG is a potent antioxidant from green tea and has selective anti - cancer cytotoxicity, which functions by interacting with proteins over - expressed specifically in cancer cells. ### Research Objectives - **Evaluating the Synergistic Effect of EGCG**: To study whether EGCG can synergistically enhance the cytotoxic effect of arecoline without protecting cancer cells. - **Exploring the Mechanism**: To explore how EGCG enhances the cytotoxic effect of arecoline by redirecting cell - cycle arrest to apoptosis. ### Main Findings - **The Synergistic Effect of EGCG and Arecoline**: EGCG not only reduces the intracellular ROS levels caused by arecoline, but also enhances the cytotoxic effect of arecoline by inducing apoptosis and cell - cycle arrest. - **Enhancement of Apoptosis**: The combination of EGCG and arecoline significantly increases the levels of apoptosis markers (such as cleavage of Caspase - 3 and PARP), and increases the proportion of cells with DNA fragmentation. - **Effect on the Cell Cycle**: EGCG can restore the cell - cycle arrest caused by arecoline and convert more G2/M - phase cells into apoptotic cells. ### Conclusion This study reveals that EGCG can synergistically enhance the cytotoxic effect of arecoline by redirecting cell - cycle arrest to apoptosis without protecting cancer cells. These findings provide a new perspective for the application of EGCG in cancer prevention and treatment.

Epigallocatechin-3-gallate Synergistically Enhanced Arecoline-Induced Cytotoxicity by Redirecting Cycle Arrest to Apoptosis

Growth inhibition of prostate cancer cells by epigallocatechin gallate in the presence of Cu2+.

Growth Inhibition of Prostate Cancer Cells by Epigallocatechin Gallate in the Presence of Cu<sup>2+</sup>

Effects of Epi-Gallocatechin Gallate on PC-3 Cell Cytoplasmic Membrane in the Presence of Cu2+

Protein Phosphatase-2A is a Target of Epigallocatechin-3-Gallate and Modulates P53-Bak Apoptotic Pathway

Distinct Effects of Tea Catechins on 6-Hydroxydopamine-induced Apoptosis in PC12 Cells

Growth Inhibition Of Prostate Cancer Cells By Epigallocatechin Gallate In The Presenceof Cu2+

Mitochondrial Modulation by Epigallocatechin 3-Gallate Ameliorates Cisplatin Induced Renal Injury Through Decreasing Oxidative/nitrative Stress, Inflammation and NF-kB in Mice.

Epigallocatechin Gallate-Β-lactoglobulin Nanoparticles Improve the Antitumor Activity of EGCG for Inducing Cancer Cell Apoptosis

Catechins Protect Against Acrylamide- and Glycidamide-Induced Cellular Toxicity Via Rescuing Cellular Apoptosis and DNA Damage.

(-)-Epigallocatechin-3-gallate Induces Non-Apoptotic Cell Death in Human Cancer Cells Via Ros-Mediated Lysosomal Membrane Permeabilization

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts

Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression

The Combined Anticancer of Peanut Skin Procyanidins and Resveratrol to CACO‐2 Colorectal Cancer Cells

(-)-Epigallocatechin-3-Gallate Attenuates the Adverse Reactions Triggered by Selenium Nanoparticles without Compromising Their Suppressing Effect on Peritoneal Carcinomatosis in Mice Bearing Hepatocarcinoma 22 Cells

Synergistic Effects of a Combination of Dietary Factors Sulforaphane and (−) Epigallocatechin-3-gallate in HT-29 AP-1 Human Colon Carcinoma Cells

In Vitro and in Vivo Study of Epigallocatechin-3-gallate-induced Apoptosis in Aerobic Glycolytic Hepatocellular Carcinoma Cells Involving Inhibition of Phosphofructokinase Activity

EGCG oxidation-derived polymers induce apoptosis in digestive tract cancer cells via regulating the renin-angiotensin system

Epigallocatechin Gallate Induces Chemopreventive Effects on Rats with Diethylnitrosamine‑induced Liver Cancer Via Inhibition of Cell Division Cycle 25A.

Application of non-invasive low-intensity pulsed electric field with thermal cycling-hyperthermia for synergistically enhanced anticancer effect of chlorogenic acid on PANC-1 cells